To include your compound in the COVID-19 Resource Center, submit it here.

Antineoplastons: Final Phase II data

Final data from an open-label, U.S. Phase II trial in 16 children showed that IV

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE